MedTrace Logo

STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot)

NCT00126360 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2005-11-10

No results posted yet for this study

Summary

This is a randomized study comparing the use of Anastrozole before and continuing during radiotherapy for breast cancer compared to the use of anastrozole after irradiation.

Conditions

Interventions

DRUG

Timing of Anastrozole in respect to radiotherapy

Sponsors & Collaborators

  • AstraZeneca

    collaborator INDUSTRY

  • St George Hospital, Australia

    lead OTHER

Principal Investigators

  • Ass. Prof. Peter H Graham, MBBS FRANZCR · Cancer Care Centre, St George Hospital, Sydney

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Completion
2016-05-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00126360 on ClinicalTrials.gov